Summary
Environmental pollutants have a strong impact on human health. It has been estimated that up to 90 per cent of all human cancers are due to exposure to chemical carcinogens. These chemicals fall mainly into the category of epigenetic or genotoxic carcinogens. The target of the genotoxic chemicals is clearly DNA. Reactive chemicals or metabolically produced intermediates bind covalently to DNA bases, and several nucleophilic substitution sites in DNA have been noted. The adduct formation in DNA is not a random process, when it is a question of bulky aromatic hydrocarbon like benzo[a]pyrene the process is highly stereoselective. The damage in DNA may be repaired efficiently and with high fidelity depending on the three-dimensional shape and location of adducts. However, if the repair fails for some reason, the DNA modified by the carcinogen may cause a mutation in cell replication. The mutation may bring about cell dysfunction which is the initiation phase of tumourigenesis. The challenge of the environmental exposure-related cancer studies are that the biological outcome is a result of the interaction of the exposure and genome of an individual. This underlines the supposition that gene-environment interactions are at the core of a specific disease outcome.
Keywords
- Polycyclic Aromatic Hydrocarbon
- Chemical Carcinogen
- Cancer Risk Assessment
- Chemical Carcinogenesis
- Environmental Carcinogen
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ames, B., and Gold, L. (1990) Too many rodent carcinogens: mitogenesis increase mutagenesis, Science 249, 970–971.
Balmain, A., and Harris, C. (2000) Carcinogenesis in mouse and human cells: parallels and paradoxes, Carcinogenesis 21, 371–377.
Bohr, V. (1995) DNA repair fine structure and its relation to genomic instability, Carcinogenesis 16, 2885–2892.
Borek, C., and Sachs, L. (1967) The number of cell generations required to fix the transformed state in X-ray induced transformation, Proc. Natl. Acad. Sci. USA 59, 83–85.
Brookes, P, and Lawley, P. (1964) Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acids, Nature 202, 781–784.
Canella, K., Peltonen, K., and Dipple, A. (1991) Identification of (+) and (-) anti benzo[a]pyrene dihydrodiol epoxide nucleic acid adducts by the 32P-postlabeling assay, Carcinogenesis 12, 1109–1114.
Culp, S., Gaylor, D., Sheldon, W., Goldstein, L., and Beland, F. (1998) A comparison of the tumours induced by coal tar and benzo[a]pyrene in a two year study, Carcinogenesis 19, 117–124.
Dipple, A. (1995) DNA adducts of chemical carcinogens, Carcinogenesis 16, 437–441.
Dipple, A., Lawley, P., and Brookes, P. (1968) Theory of tumour initiation by chemical carcinogens: dependence of activity on structure of ultimate carcinogen, Eur. J. Cancer 4, 493–506.
Dipple, A., Peltonen, K., Cheng, C., Ross, H., and Bigger, A. (1994) Chemical and mutagenic specificities of polycyclic aromatic hydrocarbons, in M. Jacobs (ed.), Diet and Cancer: Markers, Prevention an Treatment, Plenum Press, New York, pp. 101–112.
Dockery, D., Pope, C., Xu, X., Spengler, J., Ware, J., Fay, M., Ferris, B., and Speizer, F. (1993) An association between air pollution and mortality in six US cities, New England J. of Med. 329, 1753–1759.
Doll, R. (1996) Nature and nurture: possibilities for cancer control, Carcinogenesis 17, 177–184.
Doll, R., Peto, R., Wheatley, K., Gray, R., and Sutherland, I. (1994) Mortality in relation to smoking: 40 years observation on male British doctors, Br. Med. J. 309, 901–911.
Fan, A., and Howd, R. (2001) Quantitative cancer risk assessment on non-genotoxic carcinogens, in W. Choy (ed.), Genetic Toxicology and Cancer Risk Assessment, Marcel Dekker Inc., New York, 299–321.
Fedtke, N., and Swenberg, J. (1991) Quantitative analysis of DNA adducts: the potential for mass spectrometric techniques, in J. Groopman and P. Skipper (eds), Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations, CRC Press, Boca Raton, Florida, pp. 111–132.
Garner, C. (1998) The role of DNA adducts in chemical carcinogenesis, Mutat. Res. 402, 67–75.
Geacintov, N., Cosman, M., Hingerty, B., Amin, S., Broyde, S., and Patel, D. (1997) NMR solution structures of stereoisomeric polycyclic aromatic carcinogen-DNA adducts: principles, patterns and diversity, Chem. Res. Toxicol. 10, 111–131.
Gold, L., Slone, T., and Ames, B. (1998) What do animal cancer tests tell us about human cancer risk: overview of analysis of the carcinogenic potency database, Drug Metabol. Rev. 30, 359–404.
Groopman, J., and Skipper, P. (1991) Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations, CRC Press, Boca Raton, Florida.
Guengerich, P. (2000) Metabolism of chemical carcinogens, Carcinogenesis 21, 345–351.
Guengerich, P. (2001) Forking the links between metabolism and carcinogenesis, Mutat. Res. 488, 195–209.
Hemminki, K. (1993) DNA adducts, mutations and cancer, Carcinogenesis 14, 2007–2012.
Hemminki, K., Dipple, A., Shuker, D., Kadlubar, F., Segerbäck, D., and Bartch, H. (1994) DNA Adducts: Identification and Biological Significance, IARC Scientific Publications No. 125, IARC, Lyon.
Ingram, A., and Grasso, P. (1991) Evidence for and possible mechanisms on non-genotoxic carcinogenesis in mouse skin, Mutat. Res. 248, 333–340.
Jeffrey, A., Jennette, K., Blobstein, S., Weinstein, I., Beland, F., Harvey, R., Kasai, H., Miura, I., and Nakanishi, K. (1976) Benzo[a]pyrene nucleic acid derivative found in vivo: structure of benzo[a]pyrene dihydrodiol epoxide guanosine adduct, J. Am. Chem. Soc. 98, 5714–5715.
Jerina, D., and Daly, J. (1976) Oxidation of carbon, in D. Parke, and R. Smith (eds), Drug Metabolism -from Microbe to Man, Taylor and Francis, London, pp. 3–32.
Jerina, D., Sayer, J., Agarwal, S., Yagi, H., Levin, W., Wood, A., Conney, A., Pruess-Schwartz, D., Baird, W., Pigott, M., and Dipple, A. (1986) Reactivity and tumourigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons, in J. Kocsis, D. Jollow, C. Witmer, J. Nelson, and R. Snyder (eds), Biological Reactive Intermediates III, Plenum Press, New York, pp. 11–30.
Kennaway, E., and Hieger, I. (1930) Carcinogenic substances and their fluorescence spectra, Br. Med. J. 1, 1044–1046.
King, H., Osborne, M., Beland, F., Harvey, R., and Brookes, P. (1976) (+/-) 7,8-diol-9,10-epoxide of benzo[a]pyrene is an intermediate in the metabolism and binding to DNA of benzo[a]pyrene, Proc. Natl. Acad. Sci. USA 78, 2679–2681.
Knudson, A. (1985) Hereditary cancer, oncogenes and anti-oncogenes, Cancer Res. 45, 1437–1443.
Koivisto, P., Sorsa, M., Pacchierotti, F., and Peltonen, K. (1997) 32Ppostlabeling/ HPLC assay reveals an enatioselective adduct formation in N7 guanine residues in vivo after 1,3-butadiene inhalation exposure, Carcinogenesis 18, 439–443.
Koivisto, P., Adler, I-D., Pacchierotti, F., and Peltonen, K. (1998) DNA adducts in mouse testis and lung after inhalation exposure to 1,3-butadiene, Mutat. Res. 397, 3–10.
Koreeda, M., Moore, P., Yagi, H., Yeh, H., and Jerina, D. (1976) Alkylation of polyguanylic acid at the 2-amino group and phosphate by the potent mutagen benzo[a]pyrene 7,8-diol-9,10-epoxide, J. Am. Chem. Soc. 98, 6720–6722.
Koreeda, M., Moore, P., Wislocki, P., Lewin, W., Conney, A., Yagi, H., and Jerina, D. (1978) Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA and protein of mouse skin occurs with high stereoselectivity, Science 199, 778–781.
Kozak, R., Shukla, R., and Loechler, E. (1999) A hypothesis for what conformations of the major adduct of (+) anti B[]PDE (N2-dG) cause G to T versus G to A mutation based upon a correlation between mutagenesis and molecular modelling results, Carcinogenesis 20, 95–102.
Kuljukka-Rabb, T., Nylund, L., Vaaranrinta, R., Savela, K., Mutanen, P., Veidebaum, T., Sorsa, M., Rannug, A., and Peltonen, K. (2002) The effect of relevant genotypes on PAH exposure-related biomarkers, J. Exposure Analysis and Environmental Epidemiology 12, 81–91.
Lawley, P. (1974) Some chemical aspects of dose-response relationships in alkylation mutagenesis, Mutat. Res. 23, 83–295.
Loveless, A. (1969) Possible relevance of O6 alkylation of deoxyguanosine to mutagenicity of nitrosoamines and nitrosoamides, Nature 223, 206–208.
Lutz, W. (1998) Dose-response relationships in chemical carcinogenesis: Superposition of differential mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes, Mutat. Res. 405, 117–124.
Lutz, W. (2001) Dose-response relationship in chemical carcinogenesis and cancer risk assessment, in W. Choy (ed.), Genetic Toxicology and Cancer Risk Assessment, Marcel Dekker Inc., New York, pp. 249–271.
Miller, E., and Miller, J. (1947) The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene, Cancer Res. 7, 469–480.
Miller, E., and Miller, J. (198 1) Mechanism of chemical carcinogenesis, Cancer 47, 1055–1064.
Mutti, A. (1999) Biological monitoring in occupational and environmental toxicology, Toxicology Letters 108, 77–89.
Nakanishi, K., Kasai, K., Cho, H., Harvey, R., Jeffrey, A., Jennette, K., and Weinstein, I. (1977) Absolute configuration of a ribonucleic acids adduct formed in vivo by metabolism of Benzo[a]pyrene, J. Am. Chem. Soc. 99, 258–260.
Otteneder, M., and Lutz, W. (1999) Correlation of DNA adduct levels with tumour incidence: carcinogenic potency and DNA adducts, Mutat. Res. 424, 237–247.
Peltonen, K. (2001) Does diepoxybutane exposure result to DNA-DNA cross-link formation, 8th International Conference on Environmental Mutagens, October 21–26, 2001, Shizuoka, Japan.
Peltonen, K., and Dipple, A. (1995) Polycyclic aromatic hydrocarbons: Chemistry and DNA adduct formation, J. Occup. Environ. Med. 37, 52–58.
Peto, R. (1994) Smoking and death: the past 40 years and the next 40, Br. Med. J. 309, 937–939.
Phillips, D. (1990) Modern methods of DNA adduct determination, in C. Cooper, and P. Grover (eds), Handbook of Experimental Pharmacology, Springer-Verlag, Heidelberg, Germany, pp. 503–546.
Poirier, M. (198 1) Antibodies to carcinogen-DNA adducts, J. Natl. CancerInst. 67, 515–519.
Poirier, M. (1984) The use of carcinogen-DNA adduct antisera for quantisation and localization of genomic damage in animal models and the human population, Environ. Mutagenesis 6, 879–887.
Poirier, M., and Beland, F. (1992) DNA adduct measurements and tumour incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment, Chem. Res. Toxicol. 5, 749–755.
Pruess-Schwartz, D., Baird, W., Yagi, H., Jerina, D., Pigott, M., and Dipple, A. (1987) Stereochemical specificity in the metabolic activation of benzo[c]phenanthrene to metabolites that covalently bind to DNA in rodent embryo cell cultures, Cancer Res. 47, 4032–4037.
Qian, Q., Ross, R., Yu, M., Wogan, G., Qian, G., Gao, Y., and Henderson, B. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China, Cancer Epidemiol. Biomarkers Prev. 3, 3–10.
Randerath, K., Reddy, M., and Gupta, R. (1981) 32P-postlabeling test for DNA damage, Proc. Natl. Acad. Sci. USA 8, 6126–6129.
Rodriguez, H., and Loechler, E. (1993) Mutational spectra of the (+) anti diol epoxide of benzo[a]pyrene in a supF gene of an E. coli plasmid: DNA sequence context influences hotspots, mutational specificity ant the extent of SOS enhancement of mutagenesis, Carcinogenesis 14, 378–383.
Rosenkranz, H., Pollack, N., and Cunningham, R. (2000) Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena, Carcinogenesis 21, 1007–1011.
Ross, R., Yuan, J., Yu, M., Wogan, G., Qian, G., and Tu, J. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma, Lancet 339, 943–946.
Shukla, R., Geacintov, N., and Loechler, E. (1999) The major, N2-dG adduct of (+) anti B[a]PDE induces G to A mutations in a 5’-AGA-3’ sequence context, Carcinogenesis 20, 261–268.
Thakker, D., Yagi, H., Levin, W., Wood, A., Conney, A., and Jerina, D. (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens, Bioact. Foreign Compounds 7, 177–242.
Velazquez, S., Schoeny, R., Rice, G., and Cogliano, V. (1996) Cancer risk assessment: historical perspectives, current issues and future directions, Drug Chem. Toxicol. 19, 161–185.
Verna, L., Whysner, J., and Williams, G. (1996) 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumour initiation, Pharmacol. Ther. 71, 83–105.
Vogel, J., Turteltaub, K., Finkel, R., Nelson, D. (1995) Accelerator mass spectrometry: isotope identification at attomole sensitivity, Anal. Chem. 67, 353A - 359A.
Wang, L., Hatch, M., Chen, C., Levin, B., You, S., and Lu, S. (1996) Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan, Int. J. Cancer 67, 620–625.
Waters, M., Stack, H., and Jackson, M. (1999) Genetic toxicology data in the evaluation of potential human environmental carcinogens, Mutat. Res. 437, 21–49.
Yamasaki, H. (1996) Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens, Mutat. Res. 365, 91–105.
Yang, S., McCourt, D., Roller, P., and Gelboin, H. (1976) Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7, t-9,-dihydroxy-t-9, 10-oxy-7,8,9,10- tetrahydrobenzo[a]pyrene through single enatiomer of r-7, t-8-dihydroxy-7,8- dihydrobenzo[a]pyrene, Proc. Natl. Acad. Sci. USA 73, 2594–2598.
Yu, M., Lien, J., Chiu, Y., Santella, R., Liaw, Y., and Chen, C. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan, J. Hepatol. 27, 320–330.
Yuspa, S., and Poirier, M. (1988) Chemical carcinogenesis: from animal models to molecular models in one decade, Adv. Cancer Res. 50, 25–70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Peltonen, K. (2004). The Role of DNA Damage and DNA-Damaging Environmental Chemicals in Carcinogenesis. In: Nicolopoulou-Stamati, P., Hens, L., Howard, C.V., Van Larebeke, N. (eds) Cancer as an Environmental Disease. Environmental Science and Technology Library, vol 20. Springer, Dordrecht. https://doi.org/10.1007/978-0-306-48513-8_4
Download citation
DOI: https://doi.org/10.1007/978-0-306-48513-8_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2020-9
Online ISBN: 978-0-306-48513-8
eBook Packages: Springer Book Archive